Diabetes & antenatal milk expressing (DAME): a randomised controlled trial

糖尿病

• 批准号: nhmrc : GNT1005345
• 负责人: A/Pr Lisa Amir
• 金额: $ 49.13万
• 依托单位: La Trobe University
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2011
• 资助国家: 澳大利亚
• 起止时间: 2011-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/diabetes-antenatal-milk-controlled-trial/1344255
• 关键词: Diabetes; antenatal; milk; expressing; DAME

Infants of women with diabetes in pregnancy have an increased risk of low blood sugar and other complications after birth and of developing diabetes and being obese later in life. Many maternity providers encourage these women to express breast milk before birth to have it available if the infant needs supplementary feeding. Evidence for this practice is lacking so we are planning the first study exploring the safety and effectiveness of antenatal expression of breast milk in late pregnancy for women with diabetes in pregnancy.

怀孕期间患有糖尿病的女性的婴儿出生后患低血糖和其他并发症的风险增加，并且在以后的生活中患糖尿病和肥胖的风险增加。许多产妇提供者鼓励这些妇女在出生前挤出母乳，以便在婴儿需要补充喂养时提供母乳。这种做法缺乏证据，所以我们正在计划第一项研究，探索妊娠晚期母乳产前表达的安全性和有效性。